Human CD34(+) cells with in vivo repopulating potential hold much promise a
s a target for corrective gene transfer for numerous hematopoietic disorder
s. However, the efficient introduction of exogenous genes into this small,
quiescent population of cells continues to present a significant challenge.
To circumvent the need for high initial transduction efficiency of human h
ematopoietic cells, we investigated a dominant selection strategy using a v
ariant of the DHFR gene (DHFRL22Y) For this purpose, we constructed a lenti
virus-based bicistronic vector expressing EGFP and DHFRL22Y Here we demonst
rate efficient in vitro selection and enrichment of lentivirus vector-trans
duced human CD34(+) hematopoietic cells from fetal liver, umbilical cord bl
ood, bone marrow, and peripheral blood after cytokine mobilization, Growth
of transduced human CD34(+) cells in semisolid culture under selective pres
sure resulted in enrichment of transduced progenitor cells to 99.5% (n = 14
), Selection for DHFRL22Y+ cells after expansion of transduced progenitors
in liquid culture resulted in a 7- to 13-fold increase in the percentage of
marked cells. Thus we have shown that transduced human hematopoietic cells
may be effectively enriched in vitro by dominant selection, suggesting tha
t development of such strategies holds promise for future in vivo applicati
on.